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方法：健康 4 周龄 KM 小鼠 60 只，SPF 级，雌雄各一半，由厦门大学实验
动物中心提供。并且由实验动物中心按 2×107/ml 的浓度在小鼠右前腋下接种肝
癌 H22 瘤株，后在实验室常规饲养。接种后 5 天，可见肿瘤生长后开始给药。
先一次性按照 200mg/kg 的剂量予以环磷酰胺化疗，造成化疗后模型。然后分成












































待进一步研究探讨。     














Research target：At present, the incidence of cancer tends to be on the increase. 
Cancers, as a type of disease hard to be cured, pose great threat to people’s health. 
Currently, the main treatment for cancer in modern medicine is chemotherapy. But 
such way of treatment has obviously brought many side effects as well as toxic 
reactions. Besides, the long-term curative effect is not satisfying.  The recurrence 
rate seems to remain high and the patients’ quality of life is also deteriorated, which 
are two prominent problems facing the medical investigators. In fact, the Western 
medicine still lacks effective supporting treatments. Therefore the patients have to 
wait and observe whether the cancer is completely cured after some treatments. 
However, chemotherapy cannot eradicate all tumor cells; it can only increase the life 
span of the patients. It will give cancers opportunity to bounce back. Therefore, after 
treating the cancerous persons with chemotherapy, it’s helpful to apply the traditional 
Chinese medicine and its therapies. The traditional Chinese Medicine propose that: 
phlegm, deficiency and blood stasis are the basic mechanisms of cancers. According 
to the theory in traditional Chinese medicine, “Jing”, “Qi”, “Shen” are three treasures 
for human body；  Spleen and stomach act as the resource of generating and 
transforming QI and blood. Giving the fact that many patients will remain weak after 
receiving chemotherapy, if we use the methods in traditional Chinese medicine, it’s 
entirely possible to reduce the incidence of cancer and improve their life quality after 
the treatment. Moreover, it’s also hopeful to get good long-term effects. Through the 
following research, we expect to explore and confirm that “CiJi regimen for curing 
cancers” functions well in improving the alimentary system of cancers-having mice 
after receiving chemotherapy. 
Method：We chose 60 healthy 4-week-old KM mice with 30 female and 30 male. 
The mice are provided by the Experimental animal center at Xiamen University. All 














cancer at the concentration of 2×107/ml and fed normally in the animal center. 
Medicines were given to the mice 5 days after the inoculation when the cancer is seen 
to be growing. First, we conducted the chemotherapy with cyclophosphamide at the 
concentration of 200mg/kg so that the after-chemotherapy model was formed. After 
that, we divided them into 6 groups. Namely, non- injection group(1), (the mice given 
intragastric administration every day at the ratio of 1ml/10g); Cyclophosphamide 
group(2) which uses cyclophosphamide to continue the chemotherapy at the 
concentration of 200mg/kg every three days; Cis-platinum complexes group(3) which 
uses Cis-platinum complexes to continue the chemotherapy at the concentration of 
20mg/kg every three days；Chinese medicine low dose group(4) which feed the mice 
with low dose of“CiJi regimen for curing cancers” apozem (1ml apozem=0.148g 
crude drug); Chinese medicine medium dose group(5) which feed the mice with 
medium dose of “CiJi regimen for curing cancers” apozem (1ml apozem=0.297g 
crude drug); Chinese medicine high dose group(6) which feed the mice with high 
dose of “CiJi regimen for curing cancers” apozem (1ml apozem=0.445g crude drug); 
the drugs were feed to the mice every day. During the research, we observed changes 
of the mice’s fur, capacity for action and ponderal growth and recorded their amount 
of food take- in respectively. Ten days later, with ELISA, we drew their blood and test 
their gastrin, motilin, Gastric vasoactive intestinal peptide and so on.  
Result： 
1. Influence of“CiJi regimen for curing cancers” on the weight of the lab mice   
Group 1 & Group 4 & Group 5 > Group 2 & 3. Mice in group 4 gained weight 
most obviously followed by group 5 and 1. The mice in group 3 lost weight 
substantially.   
2. Influence of“CiJi regimen for curing cancers” on the food intake of the lab 
mice   
Except for Group 2 & 3 in which the mice’s food intake reduced, mice in other 
groups all took similar amount of food. Among them, mice in group 5 took a little 














3. Influence of“CiJi regimen for curing cancers” on the gastrin of the lab mice   
Group 5>group 6>…>group 1 and 3  
4. Influence of “CiJi regimen for curing cancers” on the motilin of the lab mice   
Group5>group 6>…> group 1 and 3 
5. Influence of“CiJi regimen for curing cancers”on the Gastric vasoactive 
intestinal peptide of the lab mice  
Group 2>group 5>…>group 1 
Conclusion: We can see from this research that “CiJi regimen for curing 
cancers” can obviously improve the daily health of the mice, make them gain weight 
and eat more, which resulted from the improvement of their alimentary system. Based 
on the statistics above, we may the conclude that “CiJi regimen for curing cancers” 
can increase the amount of gastrin and motilin in the blood，which suggests the 
possibility that it can improve the alimentary system. Since we are still uncertain 
about the function of the Gastric vasoactive intestinal peptide, the significance of its 
increasing amount remains to be explored.  
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体健康。根据世界卫生组织 2014 年初发表的《全球癌症报告 2014》（注：主要







































































健康 SPF 级 KM 小鼠（18-22g）60 只，雌雄各半，4 周龄，由厦门大学实
验动物中心提供，给予常规饲料喂养，自由摄食及饮水。 
2.1.2 瘤株 




电子天平 （型号：AR1502CN  奥豪斯仪器有限公司，上海） 
低速多管架自动平衡离心机 (型号：TDZ5-WS  湘仪离心机仪器有限公
司，长沙) 
ProlinePlus 移液器 （Biohit 公司，芬兰） 
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